Shandong Polymer Biochemicals Co., Ltd. Stock

Equities

002476

CNE100000TN8

Specialty Chemicals

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
3.9 CNY -2.50% Intraday chart for Shandong Polymer Biochemicals Co., Ltd. +7.14% -39.25%

Financials

Sales 2022 592M 81.8M 112M Sales 2023 387M 53.5M 73.09M Capitalization 3.93B 543M 741M
Net income 2022 29M 4.01M 5.47M Net income 2023 5M 691K 944K EV / Sales 2022 5.1 x
Net cash position 2022 294M 40.63M 55.52M Net cash position 2023 245M 33.87M 46.27M EV / Sales 2023 9.51 x
P/E ratio 2022
112 x
P/E ratio 2023
747 x
Employees 444
Yield 2022 *
-
Yield 2023
0.16%
Free-Float 75.12%
More Fundamentals * Assessed data
Dynamic Chart
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sichuan Xingtianfu Hongling Enterprise Management Co., Ltd. completed the acquisition of 15.8% stake in Shandong Polymer Biochemicals Co., Ltd. from Tibet Taiyifeng Information Technology Co., Ltd. CI
Shandong Polymer Biochemicals' Controlling Shareholder to Sell 15.8% Company Stake CI
Sichuan Xingtianfu Hongling Enterprise Management Co., Ltd. entered into equity transfer framework agreement to acquire 15.8% stake in Shandong Polymer Biochemicals Co., Ltd. from Tibet Taiyifeng Information Technology Co., Ltd. for CNY 450 million. CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Leaddiscovery Pharmaceutical Co entered into an agreement to acquire 30% interest in Dongying Lida Medical Company Co., Ltd from Shandong Polymer Biochemicals Co., Ltd. for RMB 13 million. CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Shandong Polymer Biochemicals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
1 day-2.50%
1 week+7.14%
Current month-15.58%
1 month-15.58%
3 months-29.48%
6 months-17.37%
Current year-39.25%
More quotes
1 week
3.49
Extreme 3.49
4.07
1 month
3.49
Extreme 3.49
5.12
Current year
3.49
Extreme 3.49
6.66
1 year
3.49
Extreme 3.49
6.78
3 years
3.36
Extreme 3.36
7.13
5 years
3.24
Extreme 3.24
7.90
10 years
3.24
Extreme 3.24
20.74
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 21-05-12
Director of Finance/CFO 43 22-06-08
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 61 22-06-08
Director/Board Member 60 19-03-17
Chief Executive Officer 53 21-05-12
More insiders
Date Price Change Volume
24-04-30 3.9 -2.50% 35,347,480
24-04-29 4 +9.89% 19,077,300
24-04-26 3.64 +0.28% 16,406,710
24-04-25 3.63 +3.12% 19,380,000
24-04-24 3.52 -1.95% 19,509,860

End-of-day quote Shenzhen S.E., April 29, 2024

More quotes
Shandong Polymer Bio-chemicals Co., Ltd. is a China-based company principally engaged in the businesses of energy and environmental protection. The Company operates through three main segments. The Chemical Products segment is mainly engaged in the production and sales of polyacrylamide and related chemicals for tertiary recovery and water treatment. The Oil and Gas Exploration and Development and Technical Services segment is mainly engaged in the exploration and development of oil and gas, as well as the provision of technical services, including comprehensive completed wells and oil and gas field production comprehensive management and others. The Environmental Water Treatment segment is mainly involved in the treatment of petroleum and petrochemical waste water, oil and sand, drilling fluid, fracturing fluid and others.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002476 Stock